Prospective, Randomized, Multicenter, Control Study to Assess the Efficacy and Safety of Tacrolimus in Induction and Maintenance Phase Treatment in Lupus Nephritis

NCT00615173 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

81

Enrollment

OTHER

Sponsor class

Conditions

Kidney Diseases
Lupus Nephritis
Tacrolimus
Induction Phase
Maintenance Phase

Interventions

DRUG: tacrolimus (FK506)
DRUG: cyclophosphamide or azathioprine

Sponsor

Sun Yat-sen University